Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan, Anita Afzali, David T. Rubin, Bruce E. Sands, Walter Reinisch, Julián Panés, Aparna Sahoo, Natalie A. Terry, Daphne Chan, Chenglong Han, Mary Ellen Frustaci, Zijiang Yang, William J. Sandborn, Tadakazu Hisamatsu, Jane M. Andrews, Geert D’Haens, Oleksandr Oliinyk, Leonid Bilіanskyi, Jadwiga Gniady-Jastrzebska, Robert Petryka, Tomasz Arłukowicz, Piotr Gietka, Marcin Zmudziński, Syed Mumtaz, Douglas C. Wolf, Katarzyna Wójcik‐Pszczoła, George Duvall, Monika Augustyn, Rafał Filip, Dino Tarabar, Tkachev Av, Ursula Seidler, Eran Zittan, Juris Pokrotnieks, О. Б. Щукина, Andro Machavariani, Laura Loy, Niazy Abu-farsakh, Pesegova Marina, Slobodan Srećković, Martin Laclav, Shu‐Chen Wei, Daniel R. Suiter, A Borsuk, Xavier Hébuterne, Carsten Büning, Adi Lahat-Zok, Wit Danilkiewicz, Bernadetta Frysna, Ivana Jovicic, Olena Datsenko, Maninder Guram, Animesh Jain, Zahid Rashid, Sonja Heeren, Natallia Shulga, Ivan Timkin, Srdjan Gornjakovic, Milan Lukáš, Romain Altwegg, Ariadne Desjeux, Jean‐Marie Reimund, Manana Giorgadze, Christoph Jochum, Hiroaki Ito, Katsuhiko Nakai, Tomohisa Takagi, Osamu Zaha, Chang‐Hwan Choi, Taeoh Kim, Jong Hun Lee, Ieva Stundienė, Ida Hilmi, Rosaida Hj Md Said, Jarosław Leszczyszyn, Д. И. Абдулганиева, Yu. A. Fominykh, Svetlana V Maksyashina, Jozef Baláž, Manuel Van Domselaar, Taylan Kav, Patrick Dennis, Patricia Henry, Robert Holmes, Christopher M. Johnson, Matthew J. McBride, H Sarles, Gregory Moore, R. E. Yakubtsevich, Vinciane Muls, Stevan Trbojević, Waqqas Afif, Çharles N. Bernstein, Ivo Klarin, Zuzana Šerclová, Miroslava Volfová, Pierre Desreumaux, Cyrielle Gilletta de Saint Joseph